by Elena Iemma | Apr 30, 2025 | Events
Tregs as Medicine: Tolerance and InTolerance Symposium Friday, September 26, 2025 | 9:00 am – 6:00 pm | The Westin Hotel, Meguro, Tokyo Registration is closed The inaugural Tregs as Medicine: Tolerance and InTolerance Symposium will highlight the impact...
by Elena Iemma | Apr 21, 2025 | News
The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies PROVIDENCE, R.I., April 21, 2025 /PRNewswire/ — EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling...
by Elena Iemma | Mar 1, 2025 | Blog
The EpiVax team is dedicated to advancing the science of immunogenicity assessment and streamlining the preclinical drug development process for our partners worldwide. This month, we’re excited to share several updates with you, including new and updated in silico...
by Elena Iemma | Feb 27, 2025 | News
EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements PROVIDENCE, R.I., Feb. 27, 2025 — EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax’s immunoinformatics team in 2014 and...
by Elena Iemma | Feb 24, 2025 | Blog
We know, and We Care There is not a lot of room in the TOL (Thinking out Loud) Newsletter to share our feelings about the news in the USA, but we want you to know that we ARE aware, and we REALLY CARE about the negative impact of recent...
